drugset / Trial / NCT00498004
Quality of Life (QOL) in Female Patient With Schizophrenia
RandomizedParallel-groupOpen-labelTreatment
Summary
The primary objective of this study is to demonstrate clinical and statistical superiority of quetiapine compared to risperidone in Korean version of Heinrich's Quality of Life Scale after 8 weeks trial of drugs.
Timeline
- Start
- 2007-08
- Primary completion
- 2008-09
- Completion
- 2008-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Quetiapine | Small molecule | 400 mg | — |
| Subject | Quetiapine | Small molecule | 800 mg | — |
| Subject | Risperidone | Other / unclassified | 4 mg | — |
| Subject | Risperidone | Other / unclassified | 6 mg | — |